Not yet recruitingPhase 2NCT07217665

The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen A: AADvac1

Studying Classic progressive supranuclear palsy syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Adam Boxer
Principal Investigator
Adam Boxer, MD, PhD
University of California, San Francisco
Intervention
AADvac1(biological)
Enrollment
146 enrolled
Eligibility
41-86 years · All sexes
Timeline
20252029

Collaborators

National Institute on Aging (NIA) · Alzheimer's Therapeutic Research Institute · University of Southern California · Massachusetts General Hospital · University of California, San Diego · Alzheimer's Clinical Trials Consortium · Axon Neuroscience SE

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07217665 on ClinicalTrials.gov

Other trials for Classic progressive supranuclear palsy syndrome

Additional recruiting or active studies for the same condition.

See all trials for Classic progressive supranuclear palsy syndrome

← Back to all trials